
Currently out of the existing stock ratings of Matthew Sharpe, 56 are a HOLD (55.45%), 4 are a SELL (3.96%), 41 are a BUY (40.59%).
Analyst Matthew Sharpe, has had 90.15% of price targets met with an average potential upside of 23.13%, reached in 267 days on average. Previously, Matthew Sharpe worked at MORGAN STANLEY.
Matthew Sharpe has documented 204 price targets and ratings displayed on 13 stocks. The coverage was on Industrials, Technology, Financial Services sectors.
Most recent stock forecast was given on PL, Planet Labs PBC at 12-Jun-2023.
Analyst best performing recommendations are on MAXR (MAXAR TECHNOLOGIES).
The best stock recommendation documented was for MAXR (MAXAR TECHNOLOGIES) on 12/14/2022. The price target of $42 was fulfilled within 2 days with a profit of $17.96 (74.71%), with a performance score of 373.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Dec-2025
$94
$12.98 (16.02%)
$88
11 days ago
(10-Nov-2026)
5/7 (71.43%)
$7.17 (8.26%)
57
Hold Since 27-Oct-2025
$95
$13.98 (17.25%)
$77
26 days ago
(26-Oct-2026)
5/10 (50%)
$11.64 (13.96%)
56
Hold Since 26-Oct-2026
$85
$3.98 (4.91%)
$135
26 days ago
(26-Oct-2026)
15/22 (68.18%)
$1.64 (1.97%)
205
Hold Since 02-Aug-2021
$85
$3.98 (4.91%)
$70
1 months 13 days ago
(08-Oct-2026)
24/27 (88.89%)
$12.13 (16.65%)
185
Hold Since 18-Dec-2025
$75
$-6.02 (-7.43%)
$85
1 months 14 days ago
(07-Oct-2026)
14/18 (77.78%)
$6.31 (9.19%)
294